Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases

风险与前景：一项为期11年的单中心回顾性研究，探讨接受异基因造血干细胞移植治疗非恶性疾病的儿科患者发生严重急性移植物抗宿主病（GVHD）的风险。